BridgeMD
New treatment option for Bladder
Official title Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome
ClinicalTrials.gov ID: NCT07563764
What this study is testing
- What it's testing
- Overactive bladder (OAB) is a common condition that causes urinary urgency, frequent urination, and nocturia, which can significantly affect quality of life. Women with metabolic syndrome may have a higher risk of OAB due to vascular and metabolic abnormalities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 75, women only
You may be able to join if
- Inclusion:
- Female participants aged 20 to 75 years
- Diagnosed with overactive bladder (OAB), defined as urinary frequency (≥8 times/day), nocturia (≥2 times/night), and urgency (≥2 episodes/week) for...
- Diagnosed with metabolic syndrome, defined by the presence of at least three of the following criteria:
- Waist circumference ≥80 cm
See the full eligibility criteria
- Inclusion:
- Female participants aged 20 to 75 years
- Diagnosed with overactive bladder (OAB), defined as urinary frequency (≥8 times/day), nocturia (≥2 times/night), and urgency (≥2 episodes/week) for at least 3 months
- Diagnosed with metabolic syndrome, defined by the presence of at least three of the following criteria:
- Waist circumference ≥80 cm
- Blood pressure ≥130/85 mmHg or receiving antihypertensive treatment
- Fasting glucose ≥100 mg/dL or receiving treatment for diabetes
- Triglycerides ≥150 mg/dL or receiving lipid-lowering treatment
- High-density lipoprotein cholesterol \<50 mg/dL
- No pharmacological or injection treatment for OAB within 3 months prior to enrollment
- Able to understand and comply with study procedures and questionnaires
- Willing to provide informed consent Exclusion:
- History of kidney stones or bladder stones
- Urinary tract infection within 3 months prior to enrollment or recurrent urinary tract infections (≥3 episodes)
- Lower urinary tract surgery within 6 months prior to enrollment
- Known or suspected malignancy of the urinary tract
- Significant bladder outlet obstruction
- Severe coagulopathy, liver failure, or renal failure
- Prior pelvic malignancy or pelvic radiation therapy
- Intravesical injection or electrical stimulation therapy within the past year
- Substance abuse (drug or alcohol) within the past year
- Chronic pelvic pain due to other causes
- Inability to complete study questionnaires or procedures
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.